| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |